B
BUX
vs
C
CAI
Over the past 12 months, BUX has significantly outperformed CAI, delivering a return of +148% compared to the CAI's 34% drop.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
B
|
BioMark Diagnostics Inc
CNSX:BUX
|
0.57
CAD
|
|||||
|
C
|
Caris Life Sciences Inc
NASDAQ:CAI
|
18.35
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
BUX, CAI
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
B
|
BioMark Diagnostics Inc
Revenue
|
|||||||||||
|
C
|
Caris Life Sciences Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
BUX, CAI
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
B
|
BioMark Diagnostics Inc
CNSX:BUX
|
|||||||||
|
C
|
Caris Life Sciences Inc
NASDAQ:CAI
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
B
|
BioMark Diagnostics Inc | ||||
|
C
|
Caris Life Sciences Inc | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
B
|
BioMark Diagnostics Inc | ||||
|
C
|
Caris Life Sciences Inc | ||||
Net Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
B
|
BioMark Diagnostics Inc | ||||
|
C
|
Caris Life Sciences Inc | ||||
FCF Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
B
|
BioMark Diagnostics Inc | ||||
|
C
|
Caris Life Sciences Inc | ||||
ROE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
B
|
BioMark Diagnostics Inc | ||||
|
C
|
Caris Life Sciences Inc | ||||
ROA
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
B
|
BioMark Diagnostics Inc | ||||
|
C
|
Caris Life Sciences Inc | ||||
ROIC
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
B
|
BioMark Diagnostics Inc | ||||
|
C
|
Caris Life Sciences Inc | ||||
ROCE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
B
|
BioMark Diagnostics Inc | ||||
|
C
|
Caris Life Sciences Inc | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
BUX, CAI
Performance Gap
BUX, CAI
Performance By Year
BUX, CAI
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
| US |
|
Natera Inc
NASDAQ:NTRA
|
|
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
|
| FR |
|
Biomerieux SA
PAR:BIM
|
|
| US |
|
Guardant Health Inc
NASDAQ:GH
|
|
| US |
C
|
Caris Life Sciences Inc
NASDAQ:CAI
|
|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
|
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
|
| CH |
|
Siegfried Holding AG
SIX:SFZN
|
|
| IT |
|
DiaSorin SpA
MIL:DIA
|
|
| UK |
|
Abcam PLC
LSE:ABC
|